Filter News
Area of Research
- (-) Mathematics (1)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biology and Environment (43)
- Clean Energy (96)
- Climate and Environmental Systems (4)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (6)
- Electricity and Smart Grid (1)
- Fusion and Fission (11)
- Fusion Energy (8)
- Isotopes (3)
- Materials (30)
- Materials for Computing (5)
- National Security (13)
- Neutron Science (15)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (38)
- Transportation Systems (2)
News Topics
- (-) Biomedical (2)
- (-) Clean Water (1)
- (-) Environment (1)
- (-) Fusion (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (2)
- Decarbonization (1)
- Isotopes (3)
- Materials Science (1)
- Mathematics (1)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Researchers at Oak Ridge National Laboratory have identified a statistical relationship between the growth of cities and the spread of paved surfaces like roads and sidewalks. These impervious surfaces impede the flow of water into the ground, affecting the water cycle and, by extension, the climate.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.